Form 4: Cardlytics Director Liane Hornsey Reports Stock Transactions
SEC Form 4 Filing
Director Liane Hornsey reports the vesting and conversion of restricted stock units into 11,000 shares of Cardlytics (CDLX) common stock on May 23, 2025.
Summary
- Liane Hornsey, a director of Cardlytics, Inc. (CDLX), reported a transaction involving restricted stock units (RSUs).
- On May 23, 2025, 11,000 RSUs vested and were converted into 11,000 shares of common stock.
- Following the transaction, Hornsey directly owns 22,326 shares of Cardlytics common stock.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by a company director, indicating a neutral sentiment.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future actions of key personnel.
Stakeholder Impact
- The transaction may have a minor impact on shareholders as it increases the number of shares held by a director.
Key Dates
| Date | Description |
|---|---|
| 05/23/2025 | Date of transaction: Conversion of 11,000 RSUs into common stock. |
Keywords
Cardlytics, CDLX, Director, Liane Hornsey, Form 4, Stock Transaction, Restricted Stock Units, RSU, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.